HighMark Wealth Management LLC
Position in APGE — Apogee Therapeutics, Inc.
CIK 1802451
ST. PAUL, MN
Position in APGE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,282,666
New position
Shares Held
32,266
first reported quarter
Ownership
0.043%
of shares outstanding
% of Portfolio
4.01%
of 13F equity value
Holder Rank
#125
of 281 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026HighMark Wealth Management LLC holds $13,360,619 across 36 Biotechnology names. APGE ranks #1 (32.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
This page
|
32,266 | $4,282,666 | |
| 2 | ANAB |
Anaptysbio, Inc
|
39,716 | $2,680,830 | |
| 3 | EWTX |
Edgewise Therapeutics, Inc.
|
53,179 | $2,160,662 | |
| 4 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
38,595 | $1,444,224 | |
| 5 | XENE |
Xenon Pharmaceuticals Inc.
|
23,000 | $1,388,280 | |
| 6 | AUPH |
Aurinia Pharmaceuticals Inc.
|
35,196 | $597,276 | |
| 7 | MDXG |
Mimedx Group, Inc.
|
55,878 | $215,130 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
5,310 | $207,143 |
All Filings in APGE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,282,666 | 32,266 | Shares | Sole | 2026-08-12 | |
| No filing history on record for this holder in this stock. | ||||||